Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A new STAT3-based potency assay for human G-CSF analog therapeutics.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 17, 2025
Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo.
Journal: International journal of molecular sciences
Published: June 09, 2021
Erk1/2 Inactivation-Induced c-Jun Degradation Is Regulated by Protein Phosphatases, UBE2d3, and the C-Terminus of c-Jun.
Journal: International journal of molecular sciences
Published: February 17, 2021
Erk1/2 inactivation promotes a rapid redistribution of COP1 and degradation of COP1 substrates.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 12, 2020
The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability.
Journal: Scientific reports
Published: May 24, 2019
Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation.
Journal: The Journal of biological chemistry
Published: July 05, 2017
Gastric pH and Toxin Factors Modulate Infectivity and Disease Progression After Gastrointestinal Exposure to Bacillus anthracis.
Journal: The Journal of infectious diseases
Published: June 23, 2017
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.
Journal: Science (New York, N.Y.)
Published: September 13, 2014
Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress.
Journal: The Journal of biological chemistry
Published: December 25, 2013
Last Updated: 09/26/2026